Incretin & Type 1 Diabetes

Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

April 7, 2020
Open Access

Effect of liraglutide on food consumption, appetite sensations and eating behaviours in overweight people with type 1 diabetes

Diabetes, Obesity & Metabolism
Marie-Christine DubéS John Weisnagel
July 25, 2019
Open Access

Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy

British Journal of Clinical Pharmacology
Christina BrockBirgitte Brock
July 27, 2020
Open Access

Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes

Endocrinology, Diabetes & Metabolism
Oliver SchnellAntonio Ceriello
December 21, 2019

Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model

Diabetes Technology & Therapeutics
Michelle Van NamePediatric Diabetes Consortium
June 17, 2020

Pharmaceutical Analytical Profile for Novel SGL-2 Inhibitor: Dapagliflozin

Critical Reviews in Analytical Chemistry
Saurabh B GanorkarAtul A Shirkhedkar
June 24, 2020
Open Access

Exenatide extended release in patients with type 1 diabetes with and without residual insulin production

Diabetes, Obesity & Metabolism
Kevan C HeroldRuth S Weinstock
March 29, 2020
Open Access

Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes

The Journal of Clinical Endocrinology and Metabolism
Paolo PozzilliSalim Janmohamed
June 23, 2020

Adjunct Therapies in Treatment of Type 1 Diabetes

Journal of Diabetes
Itivrita GoyalParesh Dandona
June 27, 2020
Open Access

Management of Inpatient Hyperglycemia and Diabetes in Older Adults

Clinics in Geriatric Medicine
Georgia M DavisFrancisco J Pasquel
November 24, 2019
Open Access

Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes

International Journal of Molecular Sciences
Vjera NinčevićInes Bilić Ćurčić
March 6, 2020
Comment / Editorial

GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet?

The Lancet. Diabetes & Endocrinology
Michael A Nauck, Juris J Meier
September 30, 2019
Open Access

Neuropeptide Y system mRNA expression changes in the hippocampus of a type I diabetes rat model

Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft
Elisa J CamposAntónio F Ambrósio
November 17, 2019
Open Access

GLP-1R is downregulated in beta cells of NOD mice and T1D patients

BioRxiv : the Preprint Server for Biology
Asha RecinoMaja Wallberg

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

© 2020 Meta ULC. All rights reserved